Cytokine-induced apoptosis in transformed murine fibroblasts involves synthesis of endogenous nitric-oxide

K Xie1, S Huang, Z Dong

  • 1UNIV TEXAS,MD ANDERSON CANC CTR,DEPT CELL BIOL,HMB 173,1515 HOLCOMBE BLVD,HOUSTON,TX 77030.

Insights

This study shows that endogenous nitric oxide (NO) plays a key role in cytokine-induced apoptosis of transformed fibroblasts. Inhibiting nitric oxide synthase significantly reduced cell death and DNA fragmentation.

Area of Science:

  • Cell Biology
  • Immunology
  • Biochemistry

Background:

  • Apoptosis, or programmed cell death, is crucial for normal development and tissue homeostasis.
  • Tumor necrosis factor-alpha (TNF-alpha) and other cytokines can induce apoptosis in various cell types.
  • The precise mechanisms underlying cytokine-induced apoptosis in transformed cells are not fully understood.

Purpose of the Study:

  • To investigate the role of endogenous nitric oxide (NO) synthesis in the apoptosis of murine L929 transformed fibroblasts.
  • To determine if NO production is a critical mediator in TNF-alpha, interleukin-1, and lipopolysaccharide (LPS)-induced cell death.

Main Methods:

  • Murine L929 fibroblasts (parental and TNF-alpha-resistant) were cultured in vitro.
  • Cells were treated with TNF-alpha, interleukin-1, and LPS, with or without mouse interferon-gamma (IFN-gamma).
  • Nitric oxide production was measured, and cell death was assessed via DNA fragmentation assays. N(G)-methyl-L-arginine (NMA), a nitric oxide synthase inhibitor, was used to block NO synthesis.

Main Results:

  • Combining subthreshold concentrations of IFN-gamma with cytokines or LPS induced significant cell death within 48 hours.
  • This cell death was accompanied by increased nitric oxide (NO) production.
  • The addition of NMA significantly inhibited both cell death and NO production.
  • NMA also suppressed the observed internucleosomal DNA fragmentation, a hallmark of apoptosis.

Conclusions:

  • Endogenous nitric oxide (NO) synthesis is critically involved in cytokine- and LPS-induced apoptosis of murine L929 transformed fibroblasts.
  • NO acts as a mediator in the synergistic cytotoxic effects of IFN-gamma combined with other inflammatory stimuli.
  • Targeting NO production may represent a therapeutic strategy for modulating apoptosis in certain transformed cell types.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...